Abstract
Introduction Chronic myeloid leukemia (CML) has evolved in the past 20 years from an invariably fatal disease to a long-lasting, chronic disorder that can be treated with different targeted drugs and that allows survival expectations approaching those of age-matched controls.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
